Matches in Data.gov.be for { ?s ?p Prevymis (letermovir) is indicated for prophylaxis of cytomegalovirus (CMV) reactivation and disease in adult CMV-seropositive recipients [R+] of an allogeneic haematopoietic stem cell transplant (HSCT). During the reimbursement process of Prevymis, the reimbursement commission (CRM) has proposed to enter in an article 112 with a pay-for-performance mechanism. ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- cfcba76b740b4245a85ec359572ede9e2-b2230 description "Prevymis (letermovir) is indicated for prophylaxis of cytomegalovirus (CMV) reactivation and disease in adult CMV-seropositive recipients [R+] of an allogeneic haematopoietic stem cell transplant (HSCT). During the reimbursement process of Prevymis, the reimbursement commission (CRM) has proposed to enter in an article 112 with a pay-for-performance mechanism." @default.